Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa. (2019)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vhri.2019.03.001
PubMed Identifier: 31096179
Publication URI: http://europepmc.org/abstract/MED/31096179
Type: Journal Article/Review
Volume: 19
Parent Publication: Value in health regional issues
ISSN: 2212-1099